News archive

Filter by: Reset

May 2025

- May 1, 2025
- Crown Bioscience
Crown Bioscience and NEXT Oncology Cement Partnership Extension

Crown Bioscience and NEXT Oncology renew collaboration, combining global clinical trial expertise and innovative cancer models for oncology drug development.

- April 28, 2025
- Crown Bioscience
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hemato...

Crown Bioscience launches 3D bone marrow niche in vitro models at AACR 2025, advancing predictive oncology screening for hematological malignancies.
- April 3, 2025
- KBI Biopharma
KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

KBI Biopharma, a JSR Life Sciences company, wins global recognition for excellence in biologics manufacturing at the 2025 CDMO Leadership Awards.

- March 13, 2025
- Crown Bioscience
Crown Bioscience Appoints John Gu as Chief Executive Officer

Crown Bioscience appoints John Gu as CEO, leveraging his expertise in AI-driven drug discovery to advance biotechnological innovation and global health.

- February 17, 2025
- Crown Bioscience
Crown Bioscience Completes Merger with Indivumed Services

Crown Bioscience completes Indivumed Services merger, offering enhanced drug development solutions globally and retiring the Indivumed brand.
- February 11, 2025
- Crown Bioscience
Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

Crown Bioscience's Hamburg site secures continued CAP ISO 15189:2022 accreditation, showcasing its commitment to quality in laboratory services.

- December 11, 2024
- Crown Bioscience
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Crown Bioscience wins 2024 Fierce CRO Award for excellence in client service, underscoring its commitment to innovative drug development partnerships.
- December 10, 2024
- Crown Bioscience
Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

Crown Bioscience's OrganoidXplore receives BioTech Award, revolutionizing oncology with advanced preclinical screening.
- December 3, 2024
- KBI Biopharma
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Monoclonal Antibody Candidate

KBI Biopharma Selected as CDMO of Choice to Fast-Track Development of Pre-Clinical Antibody for Blood Cancers Using SUREmAbTM Technology

- October 30, 2024
- Crown Bioscience
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biops...

Crown Bioscience, part of JSR Life Sciences, joins a €1.75M Eurostars project to develop a novel liquid biopsy for prostate cancer, enhancing treatment.
- October 1, 2024
- Crown Bioscience
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience enhances its global presence with the expansion of its Singapore facility, featuring cutting-edge oncology models and imaging capabilities.

- September 17, 2024
- JSR Corporation
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification

Amsphere™ A+ enhances antibody drug production with advanced polymer technology and high binding capacity, debuting at BPI 2024 and BioJapan.

1 of 23